1.96
price down icon2.00%   -0.04
after-market Dopo l'orario di chiusura: 1.98 0.02 +1.02%
loading

Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
41.47%
4.743
3.3527 2.4905 1.2217 1.2541
Interest Income/Expense
100.00%
-
-0.000161 - 0.2218 0.0834
Operating Income/Loss
41.47%
-4.743
-3.3527 -2.4905 -1.2217 -1.2541
Income/Loss From Continuing Operations Before Tax
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Income/Loss From Continuing Operations After Tax
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Net Income/Loss
45.15%
-4.603
-3.1712 -2.3297 -3.7005 -1.3365
Preferred Stock Dividends And Other Adjustments
100.00%
-
-1.3235 - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
698.76%
13.71
1.7163 13.66 3.5166 -0.0529
Diluted Average Shares
698.76%
13.71
1.7163 13.66 3.5166 -0.0529
Basic Earnings Per Share
183.33%
-0.34
-0.12 -0.17 -1.05 -0.40
Diluted Earnings Per Share
183.33%
-0.34
-0.12 -0.17 -1.05 -0.40
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
100.00%
-
-1.3235 - - -
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):